glp 1 drugs and gastroparesis How Dangerous Is Gastroparesis? GLP-1 Drugs And Gastroparesis: What

Description

Furthermore, slowed gastric motility also impacts drug absorption, potentially affecting medications such as beta-blockers, digoxin, opioids, and antiplatelet drugs

In addition, GLP-1 RAs have demonstrated cardioprotective effects in patients with T2DM (Grade A

Abstract Purpose of Review The purpose of this review is two-fold: (1) to discuss a case report of idiopathic intracranial hypertension (IIH) after abrupt cessation of a glucagon-like peptide-1 (GLP-1) receptor agonist with resultant rapid weight gain and (2) to review the literature regarding the potential role of GLP-1 receptor agonists in the treatment of IIH as well as potential pitfalls

Incretin-based multi-agonist peptides are neuroprotective and anti-inflammatory in cellular models of neurodegeneration

And we expect that number to rise now that one of these drugs, Wegovy, has become available in pill form, increasing its accessibility for many people